Koninklijke Deferred Long Term Liab from 2010 to 2024
| PHG Stock | USD 26.39 0.01 0.04% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 353.7 M | Current Value 515 M | Quarterly Volatility 172.5 M |
Check Koninklijke Philips financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Koninklijke Philips' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 B, Interest Expense of 290.7 M or Total Revenue of 20.6 B, as well as many indicators such as Price To Sales Ratio of 0.81, Dividend Yield of 1.0E-4 or PTB Ratio of 1.7. Koninklijke financial statements analysis is a perfect complement when working with Koninklijke Philips Valuation or Volatility modules.
Koninklijke | Deferred Long Term Liab |
Latest Koninklijke Philips' Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Koninklijke Philips NV over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Koninklijke Philips' Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Koninklijke Philips' overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Koninklijke Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 656,105,370 | |
| Geometric Mean | 633,147,793 | |
| Coefficient Of Variation | 26.30 | |
| Mean Deviation | 145,229,352 | |
| Median | 620,000,000 | |
| Standard Deviation | 172,546,759 | |
| Sample Variance | 29772.4T | |
| Range | 535.3M | |
| R-Value | (0.88) | |
| Mean Square Error | 6973.8T | |
| R-Squared | 0.78 | |
| Significance | 0.000012 | |
| Slope | (34,129,669) | |
| Total Sum of Squares | 416813.4T |
Koninklijke Deferred Long Term Liab History
About Koninklijke Philips Financial Statements
Koninklijke Philips stakeholders use historical fundamental indicators, such as Koninklijke Philips' Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Koninklijke Philips investors may analyze each financial statement separately, they are all interrelated. For example, changes in Koninklijke Philips' assets and liabilities are reflected in the revenues and expenses on Koninklijke Philips' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Koninklijke Philips NV. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 353.7 M | 515 M |
Currently Active Assets on Macroaxis
When determining whether Koninklijke Philips is a strong investment it is important to analyze Koninklijke Philips' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Koninklijke Philips' future performance. For an informed investment choice regarding Koninklijke Stock, refer to the following important reports:Check out the analysis of Koninklijke Philips Correlation against competitors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Koninklijke Philips. If investors know Koninklijke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Koninklijke Philips listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.069 | Earnings Share (0.51) | Revenue Per Share 19.75 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0136 |
The market value of Koninklijke Philips is measured differently than its book value, which is the value of Koninklijke that is recorded on the company's balance sheet. Investors also form their own opinion of Koninklijke Philips' value that differs from its market value or its book value, called intrinsic value, which is Koninklijke Philips' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Koninklijke Philips' market value can be influenced by many factors that don't directly affect Koninklijke Philips' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Koninklijke Philips' value and its price as these two are different measures arrived at by different means. Investors typically determine if Koninklijke Philips is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Koninklijke Philips' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.